Table 1.
Study Population (n = 407) | |
---|---|
Male sex | 307 (75) |
Age, years | 66 (56–75) |
FMC to PCI, min | 101 (55–120) |
Primary PCI | 346 (85) |
Medical history | |
Arterial hypertension | 261 (64) |
Dyslipidemia | 176 (43) |
Diabetes mellitus | 75 (18) |
Familiar CAD | 153 (38) |
Smoke | 139 (34) |
Previous AMI | 35 (9) |
CKD | 36 (9) |
Severe COPD | 13 (3) |
ECG at first medical contact | |
Anterior STEMI (V1–V4) | 189 (46) |
Anterior (V1–V4) and lateral (V5- V5–V6, I, aVL V6, I, aVL) | 23 (6) |
Lateral (V5–V6, I, aVL) | 14 (3) |
Inferior (II/aVF/III) | 117 (29) |
Inferior (II/aVF/III) and lateral (V5–V6, I, aVL) | 59 (14) |
Posterior | 5 (1) |
Tombstone pattern | 45 (11) |
Triangular-Lambda pattern | 14 (3) |
R-wave ≥ 1.0 mV | 125 (31) |
Culprit coronary vessel | |
Left main | 21 (5) |
LAD | 197 (48) |
Left circumflex | 52 (13) |
Ramus intermedius | 3 (1) |
Right coronary | 134 (33) |
Clinical variables | |
LVEF, % | 47 (40–55) |
GFR, mL/min/1.73 m2 | 75 (61–90) |
Killip class ≥ III | 24 (6) |
Peak Troponin I, ug/L | 70 (26–150) |
Events | |
PVF | 39 (10) |
30-day mortality | 28 (7) |
AMI = acute myocardial infarction; CAD = coronary artery disease; CKD = chronic kidney disease; COPD = chronic obstructive pulmonary disease; FMC = first medical contact; GFR = glomerular filtration rate; LAD = left anterior descending; LVEF = left ventricular ejection fraction; PCI = percutaneous coronary intervention; PVF = primary ventricular fibrillation.